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Campylobacter enteritis has emerged as one of the most common forms of human diarrheal illness. In this study
we have investigated the virulence potential of five new C. jejuni chicken isolates (RO14, RO19, RO24, RO29 and
RO37) originated from private households in the rural regions of Banat and Transylvania in Romania. Following
isolation and in vitro virulence assay, on HCT-8 cells, our results show that all the C. jejuni chicken isolates overcome
the virulence abilities of the highly virulent strain C. jejuni 81-176. Motility, an important virulence factor was significantly
improved in all the new chicken isolates. The ability to survive to the antimicrobial activity of the human serum, to resist
to the violent attack of bile acids and to survive in the presence of synthetic antibiotics was increased in all the chicken
isolates. However, these were statistically significant only for isolates RO29 and RO37. In conclusion our study shows,
based on invasiveness and motility, and also on the data provided by the serum and bile resistance experiments that
all the new chicken isolates are able to infect human cells, in vitro, and could potentially represent a health hazard
for humans.Introduction
Campylobacter jejuni is a leading cause of enteric illness in
many the western world, developing countries. Within
European Union there were 198 000 confirmed cases of
campylobacteriosis in 2009 [1]. Campylobacter jejuni be-
longs to the group of thermo-tolerant bacteria being the
most frequent cause of gastrointestinal diseases in humans.
Campylobacter enteritis is considered to be a food-bourne
disese rather than food poisoning, with infections being de-
rived from a range of foods and also water-based envi-
ronmental sources. Asymptomatic infections, watery and
bloody diarrhea have been reported in humans. Epidemio-
logical studies have shown that human Campylobacter in-
fection may vary according to geographical area and even
with age [2].
Campylobacter jejuni is present in the intestinal tract of
a wide variety of wild and domestic animals. The contam-
ination of the retail products occurs by de-feathering, evis-
ceration and dipping during slaughtering [3]. In chickens,* Correspondence: nicolae.corcionivoschi@ucd.ie
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stated.C. jejuni colonizes the mucus overlying the epithelial cells
primarily in the ceca and the small intestine but may also
be recovered from elsewhere in the gut and from the
spleen and liver [4]. Although C. jejuni is not likely to
grow or survive well in foods often between 40-85% of re-
tail poultry carcasess are C. jejuni postive [5]. Furthermore
recent studies suggest that ingestion of a small number of
C. jejuni organisms will result in human illness [6]. Little
is known about the incidence of C. jejuni infections in
Estern Europe and in particular in Romania. Once the
Eastern European countries joined European Union it be-
came of extreme importance for the food industry to as-
sess and investigate the field situation in regards to the
existent C. jejuni strains and to study their potential viru-
lence to humans.
The origin of these strains seems to be important for
their virulence and it was reported that there is a correl-
ation between pathogenicity and geographic area of origin
of Campylobacter strains [7]. Several virulence factors are
considered to be important for C. jejuni induced enteritis,
such as adhesion and invasion of epithelial cells [8], motil-
ity [9], serum resistance [10] and resistance to bile salts
[11,12]. Poultry meat is an important reservoir and source
of C. jejuni infection in Romania but little is known in
regards to the virulence of C. jejuni strains currently
present within the poultry farms. In this study we have. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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in vitro, the five chicken isolates from Banat-Transylvania
region of Romania with the C. jejuni 81-176 human isolate
which today is the model strain of choice for invasiveness
and virulence in the literature.
Material and methods
Bacterial strains and growth conditions
C. jejuni strains (n = 5) were isolated from cloacal swabs
of broilers, conventionally housed raised in small family
farms within the regions of Banat and Transylvania in
Romania, in 2013. These strains have been named
RO14, RO19, RO24, RO29 and RO37. C. jejuni 81-176
was also used as control strain in the virulence experi-
ments. All strains used in this study were stored at -80°C
in Mueller-Hinton broth containing 20% (v/v) glycerol
until required. Strains had been minimally passaged
in vitro before storage and subsequent testing. When re-
quired, bacteria were inoculated on Mueller-Hinton agar
containing selective Skirrow’s antibiotics (Oxoid) and
grown under microaerobic conditions (5% CO2, 5% O2,
90% N2) at 42°C. After 24 h growth, a loopful of bacteria
was inoculated into biphasic media containing Mueller-
Hinton agar and RPMI 1640 tissue culture media sup-
plemented with 10% fetal calf serum. This was cultured
for 18 h at 42°C microaerobically for invasion assays.
These conditions were determined in preliminary studies
as optimum growth conditions for the invasion assay.
The isolation of strains has been done accordingly to the
legislation in place (Law 471/2002 and government or-
dinance 37/2002) under the supervision of National
Sanitary Veterinary Agency. The ethics committee of
Banat University of Agricultural Sciences and Veterinary
Medicine – King Michael I of Romania, approved this
work.
Bacterial isolation and identification
Biological material: Chicken broilers from 6 intensive
breeding facilities from the West part of Romania. From
each breeding unit 3 animals were taken for study, a
total of 18 animals were used for this study. Sample
collection: Cloaca swabs were recovered using a sterile
cotton swab, after collection the sample was sealed into
a sterile plastic tube and transported to the laboratory.
The fecal samples were collected from cecum directly
into the laboratory, under sterile conditions, for this the
cecum was recovered from the animals into a sterile
petri dish and transported in the laboratory. Within 15-
20 minutes from collection the samples were processed.
Bacterial isolation: The sample from cloaca swab was
dissolved into 900 μl sterile water, after that serial dilu-
tions were performed until 105 and 100 μl of each dilu-
tion was plated on to 9.5 cm Petri dish with Muller
Hinton Agar media (CM0337, Thermo scientific), preparedaccording to the producer instructions. For the feces sample
approximately 100 μl of the cecum content was diluted into
900 μl of sterile water, and serial dilutions was performed
from this. Dilutions from 102 to 106 were plated on the
same media as swab samples. After 72-96 hours of incuba-
tion at 37°C, in microaerophilic conditions, colonies with
Campylobacter sp. aspect were picked and inseminated on
Muller-Hinton agar media supplemented with campylobac-
ter selective supplement (Skirrow, SR0069, Thermo scien-
tific). All plates were incubated at 37°C in microaerophilic
conditions using CampyGen AGS (CN0025A, Thermo
scientific). The identification of the isolates was per-
formed with conventional (sodium hippurate hydrolysis
and commercial identification system (Api CAMPY sys-
tem, bioMerieux, France).
Infection assays
The gentamicin protection assay was used to test the
ability of C. jejuni chicken isolates by comparison with
the highly virulent strain C. jejuni 81-176 to adhere and
invade human instestinal epithelial cells [10]. Briefly,
HCT-8 cells were grown (60% confluence) for 15 to 18 h
in six-well tissue culture plates at a concentration of 1 ×
105 cells per well. Plate grown C. jejuni 81-176 wild type
and C. jejuni chicken isolates were washed and re-
suspended in tissue culture medium at an OD600 of 0.4.
The HCT-8 cells were washed with PBS, and 2 ml of
fresh culture medium was added to each well. Bacteria
were added to give a multiplicity of infection of 10. Tis-
sue culture plates were centrifuged at 250 × g for 5 min
and incubated for 3 h at 37°C in 10% CO2. To quantify
the number of cell-associated bacteria, infected mono-
layers were washed at least three times with PBS and
treated with 0.1% Triton X-100 in PBS at 37°C for 30 mi-
nutes. Tenfold dilutions of each well were plated onto
the appropriate agar and colonies enumerated after
3 days of incubation. To quantify the number of bacteria
that invaded HCT-8 cells, the infected monolayers were
washed with PBS and tissue culture medium (2 ml) con-
taining gentamicin (400 μg/ml) was added to half the
wells, and medium with no antibiotic was added to the
remaining wells. The tissue culture plates were then in-
cubated for a further 2 h at 37°C and washed with PBS.
HCT-8 cells were lysed by the addition of 100 μl of 0.1%
Triton X-100 in PBS and incubated for 10 to 15 min at
37°C. Tenfold dilutions of the contents of each well were
plated on Mueller Hinton agar and colonies were enu-
merated after 3 days of incubation. Invasion efficiency
was calculated as the average of the total number of
CFU/total initial inoculum. C. jejuni 81-176 passaged in
RPMI 1640 (without cells) was also tested for the ability
to adhere to and invade HCT-8 cells. The experiments
were conducted on three separate occasions. Results for
a representative experiment are presented. The error
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wells.. The significance of differences in adhesion and in-
vasion between samples was determined using the Stu-
dent t test. A P value of <0.05 was defined as significant.
Motility assays
The motility experiments were done according with the
method previously described [13]. Five microliters of
culture was inoculated into the center of the Mueller
Hinton agar plates (0.4% agar), and the diameter of the
resulting swarms was measured the next day, following
incubation for 24 hours at 42°C in microaerbic condi-
tions. Motility was characterized like an area of growth
around the central point of the plate and measured in
millimeters.
Serum resistance
The sensitivity of bacteria to human serum (Invitrogen)
was measured. C.jejuni 81-176 wild type and the chicken
isolates (RO14, RO19, RO24, RO29 and RO37) were
plate-grown and resuspended in fresh tissue culture
medium (RPMI 1640) to give an OD600 of 0.1. Five mi-
croliters of bacterial suspension was added to duplicate
wells of a six-well plate containing 800 μl of Mueller-
Hinton broth and 200 μl of active pooled human serum
or to separate wells containing 800 μl of Mueller-Hinton
broth and 200 μl heat-inactivated human serum. The
plates were incubated for 1 h at 37°C under microaero-
bic conditions. Bacteria from each well were diluted 10-
fold and plated on dry Mueller-Hinton agar plates. The
plates were incubated at 37°C under microaerobic condi-
tions. Colony counts were performed after an incubation
time of 2 days. All assays were conducted in triplicate
and repeated independently three times.
Resistance to bile salts
MH broth was supplemented with 4.0% (wt/vol) bile
salts and 50 mL of media was transferred into 100 ml
bottles for each treatment for the chicken isolates and C.
jejuni 81-176. The medium was then autoclaved and,
once cooled, 1 ml of either chicken isolates or C. jejuni
81-176 cells were transferred to each bottle. This experi-
ment was carried out in triplicate. The bottles were left
in optimum growth conditions for 24 hours after which
20 μl was removed and diluted with 100 μl of water. The
series of dilutions were then plated as before and a sec-
ond set of samples were obtained and diluted after a fur-
ther 18 hours. Viable cell counts for each plate were
determined at the end of the incubation period.
Antimicrobial resistance
Six antibiotics (nalidixic acid, ciprofloxacin, erythromycin,
ampicillin, amoxicillin-clavulanic acid and gentamicin)
were tested using the disk E test (Solna, Sweeden). Thebacterial inoculum was adjusted to 0.5 McFarland standard
turbidity and Mueller–Hinton agar supplemented were
used. Bacterial suspension was inoculated in Mueller-
Hinton agar Petri dishes. When the plates were dry, six
antimicrobial disks were applied per plate and incubated
over night in microaerobic conditions at 37°C.
Statistical analysis
Experiments were conducted on at least three separate oc-
casions in triplicates. Results are presented as the means ±
standard deviations (error bars) of three replicate experi-
ments. Graphs were drawn using Prism, and the unpaired
Student t test was used to estimate statistical significance.
A P value of <0.05 was considered significant.
Results
Adhesion and invasiveness of C. jejuni strains isolated
from poultry
The virulence of the five chicken isolates (RO14, RO19,
RO24, RO29 and RO37) was tested using HCT-8 cells
and adhesion/invasion were compared with the model
strain C. jejuni 81-176, to correct for experimental vari-
ation. Invasiveness varied considerably between the in-
vestigated strains, as is shown in Figure 1A (adhesion)
and B (invasion). Following gentamicin protection assay
we have shown that the total adhesion of the chicken
isolates is significantly increased compared to the total
adhesion of C. jejuni 81-176. From the distribution pro-
file obtained the most significant increase in adhesion
was recorded for isolate RO37. Normally adhesion levels
are not always associated with an increase in the number
of bacteria that penetrate the epithelial cells. However,
for the C. jejuni chicken isolates described in this study
this was not the case as higher levels of internalization
were found in all isolated strains. Similarly, to the adhe-
sion results, the chicken isolate RO37 had the highest
internalization levels compared to C. jejuni 81-176.
Motility of poultry isolated C. jejuni strains
Motility was previously described as an important viru-
lence factor in C. jejuni described [9]. Based on our results,
showing improved adhesion and invasion of all the chicken
isolates, next we have investigated their motility. As ex-
pected all these new strains showed increased motility
compared to the control strain C. jejuni 81-176 as judged
by the increased migration in semisolid agar (Figure 2),
which correlates with their increase in virulence. Statisti-
cally all the increases in motility were significant but simi-
larly as for adhesion/invasion the most significant increase
was observed for strain RO37 (p < 0.0001).
Resistance to human serum
The ability of C. jejuni to cause systemic infection in
imuncompromised hosts it was suggested to be related
Figure 1 Increased adhesion and invasion for all chicken
isolates. (A) adhesion to HCT-8 cells, (B) invasion of HCT-8 cells of
C. jejuni 81-176 and C. jejuni chicken isolates RO14, RO19, RO24,
RO29 and RO37. Statistical significance (Student’s t test) relative to
the level of C. jejuni 81-176 strain is indicated. The experiments were
done in triplicate and on three separate occasions. The error bars
represent standard deviations for six separate wells.
Figure 2 Motility of C. jejuni chicken isolates in 0.4% motility
agar. Motility of C. jejuni chicken isolates RO14, RO19, RO24, RO29
and RO37 by comparison with the highly virulent strain C. jejuni 81-
176. Size of the motility halo after 48 h at 37°C. Results are the mean
of three separate experiments. Statistical significance (Student’s t
test) relative to the level of C. jejuni 81-176 strain is indicated.
Figure 3 Serum resistance. Serum resistance of C. jejuni chicken
isolates RO14, RO19, RO24, RO29 and RO37 by comparison to C.
jejuni 81-176. The survival rate is defined as the number of C. jejuni
colonies isolated following exposure to human serum divided by
the number of colonies surviving in heat-inactivated serum,
expressed as a percentage. The experiment was performed in tripli-
cate. The error bars represent standard deviations. Statistical signifi-
cance was assessed with Student’s t test.
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present in the serum of these patients [14]. Suerly, this
will not be the case with the human serum (Invitrogen)
and we have investigated the serum survival rate of these
newly chicken isolated strains. As shown in Figure 3 the
isolates RO14 (p = 0.25), RO19 (p = 0.15) and RO24 (p =
0.17) had a better rate of survival in human serum but
not statistically significant. However, the isolates RO29
(p = 0.03) and RO37 (p = 0.0001) had a significantly
incresed serum survival rate (Figure 3) compared to the
control strain C. jejuni 81-176.
Resistance to bile salts
In order to fulfill its pathogenicity, in vivo, C. jejuni must
resist the deleterious actions of bile in order to survive
in the human gastrointestinal tract. This experimentaimed to observe any differences between the response of
C. jejuni 81-176 and chickens isolates to elevated levels of
bile salts in the media and, as a result, speculate on their
behaviour within their normal habitat of the intestine. The
chicken isolates RO14, RO19 and RO24 had a percentage
of survival similar to C. jejuni 81-176 (Figure 4). The most
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chicken isolate RO29 where the increase was over 30%
(p < 0.0001). The chickens isolate RO37, which has been
proven also to be the most virulent (Figure 1B) an increase
of in bile resistance of 15% was detected.
Antimicrobial resistance
For each C. jejuni isolate antibiotic inhibition zones to
the various antibiotics were recorded and compared to
the resistance of C. jejuni 81-176 control strain. The
antibiotic profiles of the C. jejuni poultry isolates were
different to the profiles of C. jejuni 81-176 control strain
which shwed restitace only to gentamicin (Table 1). Only
two of the chicken isolates were senzitive to nalidixic
acid (RO19 and RO24). The resistance to erythromycin
and ampicillin was detected for all the chicken isolates
but interestingly not for the control strain. For ciproflox-
acin and amixicillin-clavulinic acid the resistance profiles
of the chicken isolates matched the profile of C. jejuni
81-176, lack of resistance being detected for all of them.
Resistance to gentamicin was detected for RO19, RO29
and RO37 chicken isolates and also for the control strain
C. jejuni 81-176.
Discussions
In 2010 the European Centre for Disease Prevention and
Control (EFSA) reported that campylobacteriosis is still
the most common zoonosis in the European Union (EU)
[15]. In the past ten years a total of 13 new countries inFigure 4 Bile resistance. The ability of C. jejuni chicken isolates
(RO14, RO19, RO24, RO29, RO37) and C. jejuni 81-176 to survive to
bile salts in Mueller Hinton medium was studied. Following agar
growth bacteria were transferred into 50 mL of medium containing
0.5% bile salts. Samples were removed after 24 h and diluted prior
plating. The surviving cells were counted after 42 h incubation. The
experiments were done in triplicates and Student t test was used for
statistical significance.Eastern Europe joined the EU and currently very little is
known in regards to the virulence of C. jejuni strains
currently present in those areas. In humans the most
common cause of campylobacter enteritis is caused by
C. jejuni which commonly colonizes the intestinal tract
of chickens [16]. It is now recognized that in some coun-
tries in Eastern Europe, especially in suburban areas,
much of the population grow chicken broilers for their
own consumption. Therefore our study focused on the
isolation and investigation of the virulence characte-
ristics of C. jejuni strains isolated from households in
rural areas in the regions of Banat and Transylvania of
Romania.
An essential feature in the development of an infec-
tious disease is the initial transport of the bacterial
pathogen to the host. In chickens, C. jejuni will only
colonize the mucosa without entering the epithelial cells.
The success in colonization will depend on the ability of
bacteria to compete successfully with the host’s normal
microbiota for essential nutrients. However, in the hu-
man gut C. jejuni will have to will have to not only to
perform colonization but also internalization in order to
cause infection. In order to achieve this the pathogen
will have fulfill few conditions for an efficient infection
that includes: high motility [17], to out rule the detri-
mental effects of the bile [18], to express efficiently ad-
hesion molecules [19,20] and if the infection becomes
systemic to survive the antimicrobial effect of the human
serum [21].
The mechanisms by which Campylobacter species
cause diarrhea and possible subsequent sequelae are not
well defined. Invasion and adhesion are generally an im-
portant pathogenic factor and it was reported for clinical
and non-clinical isolates [22,23]. In our experiments all
the chicken isolates were significantly more adherent
and invasive compared to the control strain C. jejuni 81-
176. This finding is consistent with previous reported
data showing that chicken isolates are more or at least
as invasive as human isolates [11]. Studies with isolated
primary cells from chickens showed that C. jejuni was
able to invade chicken cells [24] and that invasion is
largely dependent on strain isolates.
Motility plays and important role in Campylobacter
colonization, since the organism has to penetrate mucus
in order to adhere to and invade surface epithelial cells.
In our study the motility of the five chicken isolates,
found to have different virulence potential following
examination on motility agar. The role of motility has
been previously demonstrated in several animal models
[25] and also on human volunteer experiments [26]. We
have also shown previously that diminished motility re-
sults in reduced ability of C. jejuni 81-176 to infect hu-
man epithelial cells [13]. The increased motility of the
new chicken isolates will be of great importance for
Table 1 Antimicrobial resistance rates of C. jejuni isolated from poultry
Specie Nalidixic acid Ciprofloxacin Erythromycin Ampicillin Amoxicilin-clavulanic acid Gentamicin
C. jejuni 81-176 - - - - - +
RO14 + - + + - -
RO19 - - + + - +
RO24 - - + + - -
RO29 + - + + - +
RO37 + - + + - +
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pact on their the ability to cause disease.
When systemic C. jejuni occurs in an immunocom-
promised individual the bacterium will have to over-
come the antimicrobial activity of the human serum.
This antibacterial activity of a serum component is an
important innate defense against bacteria within the
vascular compartment. Using fresly pooled human
serum we show that only two of the chicken isolates
(RO29 and RO37) were significantly more resistant
compared to C. jejuni 81-176. The resistance to human
serum, of these two strains, might arise from unique
surface charcateristics allowing them to evade the bac-
tericidal effect of serum complements. How and why
these new isolates are more virulent requires investiga-
tion of important virulence factors including capsule
polysaccharide (CPS). The amount of CPS was shown to
be important for the survival of C. jejuni to human
serum [27]. One important feature involved in serum
resistance reffers to the protein structure of the S-layer
which is also involved in mediating bacterial resistance
to human serum. These proteins will confer resistance
to complement-mediated killing by using opsonic anti-
bodies directed against the S-layer [28].
Little is known on the bile tolerance of Gram-negative
bacteria, but it is belived that they are more resistant to
bile than Gram-positive bacteria. An adaptation that is
vital to the survival of Campylobacter in the gut and,
hence, its success in causing infection, is its ability to
withstand the presence of bile salts in the surrounding
environment. Such an adaptation will serve as a com-
petitive advantage over other bacteria colonising the gut.
The volume of the bile salt pool in man has been esti-
mated as either 4 g or 7.6 mmol was identified as 7.6 ±
0.9 mmol, which is secreted and reabsorbed at least
twice during the digestion of a single meal [29]. Our re-
sults show that, at least for two of the chicken isolates
(RO29 and RO37) their survival rates in the presence of
bile acids were significantly higher when compared to
the survival rate of C. jejuni 81-176. This increase in sur-
vival to the bile acids could have a positive impact on
the pathogenic abilities of this two strains and corelate
to the other virulence traits here identified.In most cases Campylobacter infections are acute and
self-limited in nature and will not require antibiotic
treatment, unless infections occur in immunocomprom-
ised patients. Unfortunately, not all the laboratories will
routinely perform antimicrobial testing of new C. jejuni
isolates. In our experiments the resistance to erythro-
mycin was very high in all C. jejuni chicken isolates
similarly to what was previously reported in the litera-
ture [30]. The resistance to erythromycin, in the new C.
jejuni chicken isolates, was not acquired via plasmid
conjugation since the erythromycin resistance is unre-
lated to the presence of plasmid DNA and therefore is
considered to be chromosomally mediated [31]. The
production of beta-lactamases in bacteria is associated
with resistance to ampicillin and in our experiments all
the C. jejuni chicken isolates are highly resistant to
ampicillin.
However, when an antibiotic resistant to beta-lactamases
is used (combination of amoxicillin and clavulanic acid), all
the new C. jejuni chicken isolates were not able to survive.
In conclusion, we have shown that C. jejuni chicken iso-
lates exhibit a range of invasion phenotypes with hyper
invasiveness being more frequently observed among
C. jejuni chicken isolates. However, extrapolating these
results to the host it is premature at this stage because C.
jejuni infection is highly dependent on the physiological
and immunological condition of the host.
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